Acute stimulation of the soluble guanylate cyclase does not impact on left ventricular capacitance in normal and hypertrophied porcine hearts in vivo

Standard

Acute stimulation of the soluble guanylate cyclase does not impact on left ventricular capacitance in normal and hypertrophied porcine hearts in vivo. / Alogna, Alessio; Schwarzl, Michael; Manninger, Martin; Hamdani, Nazha; Zirngast, Birgit; Kloth, Benjamin; Steendijk, Paul; Verderber, Jochen; Zweiker, David; Westermann, Dirk; Blankenberg, Stefan; Maechler, Heinrich; Tschöpe, Carsten; Linke, Wolfgang A; Marsche, Gunther; Pieske, Burkert M; Post, Heiner.

In: AM J PHYSIOL-HEART C, Vol. 315, No. 3, 01.09.2018, p. H669-H680.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Alogna, A, Schwarzl, M, Manninger, M, Hamdani, N, Zirngast, B, Kloth, B, Steendijk, P, Verderber, J, Zweiker, D, Westermann, D, Blankenberg, S, Maechler, H, Tschöpe, C, Linke, WA, Marsche, G, Pieske, BM & Post, H 2018, 'Acute stimulation of the soluble guanylate cyclase does not impact on left ventricular capacitance in normal and hypertrophied porcine hearts in vivo', AM J PHYSIOL-HEART C, vol. 315, no. 3, pp. H669-H680. https://doi.org/10.1152/ajpheart.00510.2017

APA

Alogna, A., Schwarzl, M., Manninger, M., Hamdani, N., Zirngast, B., Kloth, B., Steendijk, P., Verderber, J., Zweiker, D., Westermann, D., Blankenberg, S., Maechler, H., Tschöpe, C., Linke, W. A., Marsche, G., Pieske, B. M., & Post, H. (2018). Acute stimulation of the soluble guanylate cyclase does not impact on left ventricular capacitance in normal and hypertrophied porcine hearts in vivo. AM J PHYSIOL-HEART C, 315(3), H669-H680. https://doi.org/10.1152/ajpheart.00510.2017

Vancouver

Bibtex

@article{9e7360a0d17b4c569a273a2cff37ce9f,
title = "Acute stimulation of the soluble guanylate cyclase does not impact on left ventricular capacitance in normal and hypertrophied porcine hearts in vivo",
abstract = "Experimental data indicate that stimulation of the nitric oxide-soluble guanylate cyclase(sGC)-cGMP-PKG pathway can increase left ventricular (LV) capacitance via phosphorylation of the myofilamental protein titin. We aimed to test whether acute pharmacological sGC stimulation with BAY 41-8543 would increase LV capacitance via titin phosphorylation in healthy and deoxycorticosteroneacetate (DOCA)-induced hypertensive pigs. Nine healthy Landrace pigs and 7 pigs with DOCA-induced hypertension and LV concentric hypertrophy were acutely instrumented to measure LV end-diastolic pressure-volume relationships (EDPVRs) at baseline and during intravenous infusion of BAY 41-8543 (1 and 3 μg·kg-1·min-1 for 30 min, respectively). Separately, in seven healthy and six DOCA pigs, transmural LV biopsies were harvested from the beating heart to measure titin phosphorylation during BAY 41-8543 infusion. LV EDPVRs before and during BAY 41-8543 infusion were superimposable in both healthy and DOCA-treated pigs, whereas mean aortic pressure decreased by 20-30 mmHg in both groups. Myocardial titin phosphorylation was unchanged in healthy pigs, but total and site-specific (Pro-Glu-Val-Lys and N2-Bus domains) titin phosphorylation was increased in DOCA-treated pigs. Bicoronary nitroglycerin infusion in healthy pigs ( n = 5) induced a rightward shift of the LV EDPVR, demonstrating the responsiveness of the pathway in this model. Acute systemic sGC stimulation with the sGC stimulator BAY 41-8543 did not recruit an LV preload reserve in both healthy and hypertrophied LV porcine myocardium, although it increased titin phosphorylation in the latter group. Thus, increased titin phosphorylation is not indicative of increased in vivo LV capacitance. NEW & NOTEWORTHY We demonstrate that acute pharmacological stimulation of soluble guanylate cyclase does not increase left ventricular compliance in normal and hypertrophied porcine hearts. Effects of long-term soluble guanylate cyclase stimulation with oral compounds in disease conditions associated with lowered myocardial cGMP levels, i.e., heart failure with preserved ejection fraction, remain to be investigated.",
keywords = "Animals, Blood Pressure, Cardiomegaly/etiology, Connectin/metabolism, Cyclic GMP/metabolism, Cyclic GMP-Dependent Protein Kinases/metabolism, Desoxycorticosterone Acetate/toxicity, Female, Heart Ventricles/drug effects, Morpholines/pharmacology, Nitroglycerin/pharmacology, Pyrimidines/pharmacology, Soluble Guanylyl Cyclase/metabolism, Swine, Vascular Capacitance, Vasodilator Agents/pharmacology, Ventricular Function, Left",
author = "Alessio Alogna and Michael Schwarzl and Martin Manninger and Nazha Hamdani and Birgit Zirngast and Benjamin Kloth and Paul Steendijk and Jochen Verderber and David Zweiker and Dirk Westermann and Stefan Blankenberg and Heinrich Maechler and Carsten Tsch{\"o}pe and Linke, {Wolfgang A} and Gunther Marsche and Pieske, {Burkert M} and Heiner Post",
year = "2018",
month = sep,
day = "1",
doi = "10.1152/ajpheart.00510.2017",
language = "English",
volume = "315",
pages = "H669--H680",
journal = "AM J PHYSIOL-HEART C",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "3",

}

RIS

TY - JOUR

T1 - Acute stimulation of the soluble guanylate cyclase does not impact on left ventricular capacitance in normal and hypertrophied porcine hearts in vivo

AU - Alogna, Alessio

AU - Schwarzl, Michael

AU - Manninger, Martin

AU - Hamdani, Nazha

AU - Zirngast, Birgit

AU - Kloth, Benjamin

AU - Steendijk, Paul

AU - Verderber, Jochen

AU - Zweiker, David

AU - Westermann, Dirk

AU - Blankenberg, Stefan

AU - Maechler, Heinrich

AU - Tschöpe, Carsten

AU - Linke, Wolfgang A

AU - Marsche, Gunther

AU - Pieske, Burkert M

AU - Post, Heiner

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Experimental data indicate that stimulation of the nitric oxide-soluble guanylate cyclase(sGC)-cGMP-PKG pathway can increase left ventricular (LV) capacitance via phosphorylation of the myofilamental protein titin. We aimed to test whether acute pharmacological sGC stimulation with BAY 41-8543 would increase LV capacitance via titin phosphorylation in healthy and deoxycorticosteroneacetate (DOCA)-induced hypertensive pigs. Nine healthy Landrace pigs and 7 pigs with DOCA-induced hypertension and LV concentric hypertrophy were acutely instrumented to measure LV end-diastolic pressure-volume relationships (EDPVRs) at baseline and during intravenous infusion of BAY 41-8543 (1 and 3 μg·kg-1·min-1 for 30 min, respectively). Separately, in seven healthy and six DOCA pigs, transmural LV biopsies were harvested from the beating heart to measure titin phosphorylation during BAY 41-8543 infusion. LV EDPVRs before and during BAY 41-8543 infusion were superimposable in both healthy and DOCA-treated pigs, whereas mean aortic pressure decreased by 20-30 mmHg in both groups. Myocardial titin phosphorylation was unchanged in healthy pigs, but total and site-specific (Pro-Glu-Val-Lys and N2-Bus domains) titin phosphorylation was increased in DOCA-treated pigs. Bicoronary nitroglycerin infusion in healthy pigs ( n = 5) induced a rightward shift of the LV EDPVR, demonstrating the responsiveness of the pathway in this model. Acute systemic sGC stimulation with the sGC stimulator BAY 41-8543 did not recruit an LV preload reserve in both healthy and hypertrophied LV porcine myocardium, although it increased titin phosphorylation in the latter group. Thus, increased titin phosphorylation is not indicative of increased in vivo LV capacitance. NEW & NOTEWORTHY We demonstrate that acute pharmacological stimulation of soluble guanylate cyclase does not increase left ventricular compliance in normal and hypertrophied porcine hearts. Effects of long-term soluble guanylate cyclase stimulation with oral compounds in disease conditions associated with lowered myocardial cGMP levels, i.e., heart failure with preserved ejection fraction, remain to be investigated.

AB - Experimental data indicate that stimulation of the nitric oxide-soluble guanylate cyclase(sGC)-cGMP-PKG pathway can increase left ventricular (LV) capacitance via phosphorylation of the myofilamental protein titin. We aimed to test whether acute pharmacological sGC stimulation with BAY 41-8543 would increase LV capacitance via titin phosphorylation in healthy and deoxycorticosteroneacetate (DOCA)-induced hypertensive pigs. Nine healthy Landrace pigs and 7 pigs with DOCA-induced hypertension and LV concentric hypertrophy were acutely instrumented to measure LV end-diastolic pressure-volume relationships (EDPVRs) at baseline and during intravenous infusion of BAY 41-8543 (1 and 3 μg·kg-1·min-1 for 30 min, respectively). Separately, in seven healthy and six DOCA pigs, transmural LV biopsies were harvested from the beating heart to measure titin phosphorylation during BAY 41-8543 infusion. LV EDPVRs before and during BAY 41-8543 infusion were superimposable in both healthy and DOCA-treated pigs, whereas mean aortic pressure decreased by 20-30 mmHg in both groups. Myocardial titin phosphorylation was unchanged in healthy pigs, but total and site-specific (Pro-Glu-Val-Lys and N2-Bus domains) titin phosphorylation was increased in DOCA-treated pigs. Bicoronary nitroglycerin infusion in healthy pigs ( n = 5) induced a rightward shift of the LV EDPVR, demonstrating the responsiveness of the pathway in this model. Acute systemic sGC stimulation with the sGC stimulator BAY 41-8543 did not recruit an LV preload reserve in both healthy and hypertrophied LV porcine myocardium, although it increased titin phosphorylation in the latter group. Thus, increased titin phosphorylation is not indicative of increased in vivo LV capacitance. NEW & NOTEWORTHY We demonstrate that acute pharmacological stimulation of soluble guanylate cyclase does not increase left ventricular compliance in normal and hypertrophied porcine hearts. Effects of long-term soluble guanylate cyclase stimulation with oral compounds in disease conditions associated with lowered myocardial cGMP levels, i.e., heart failure with preserved ejection fraction, remain to be investigated.

KW - Animals

KW - Blood Pressure

KW - Cardiomegaly/etiology

KW - Connectin/metabolism

KW - Cyclic GMP/metabolism

KW - Cyclic GMP-Dependent Protein Kinases/metabolism

KW - Desoxycorticosterone Acetate/toxicity

KW - Female

KW - Heart Ventricles/drug effects

KW - Morpholines/pharmacology

KW - Nitroglycerin/pharmacology

KW - Pyrimidines/pharmacology

KW - Soluble Guanylyl Cyclase/metabolism

KW - Swine

KW - Vascular Capacitance

KW - Vasodilator Agents/pharmacology

KW - Ventricular Function, Left

U2 - 10.1152/ajpheart.00510.2017

DO - 10.1152/ajpheart.00510.2017

M3 - SCORING: Journal article

C2 - 29727215

VL - 315

SP - H669-H680

JO - AM J PHYSIOL-HEART C

JF - AM J PHYSIOL-HEART C

SN - 0363-6135

IS - 3

ER -